قالب وردپرس درنا توس
Home / Tips and Tricks / Do we get a vaccine against coronavirus 2020? Everything you need to know

Do we get a vaccine against coronavirus 2020? Everything you need to know



    gettyimages-1209302220

Experts hope that a vaccine against the SARS-CoV-2 virus will be available sooner rather than later.

SOPA Images / Getty Images

Visit the WHO website for the latest updates and information on the coronavirus pandemic.

If we seem to be stuck in a holding pattern while waiting for one or more vaccines to run out coronavirus pandemic, it’s because we are. Experts agree that without a vaccine, the only ways to contain the virus are the things we already do: wearing masks, social distancing, testing followed by contact tracking. But these measures are effective when strictly followed uncomfortable at best and purely political charged in the worst case – not to mention, people seem to have a hard time following them.

This is why relieving locking limitations almost always leads to one spike in new cases of coronavirus, which calls on government leaders to bring back lockdowns. The only thing that is expected to break that cycle is a vaccine. So, how much longer do we have to wait, and where are we in the vaccine development process now?

If you live in the industrialized world, according to Bill Gates, make no major plans for next year or so. “For the rich world, we should largely be able to end this thing by the end of 2021, and for the world at large by the end of 2022,” he told Wired.

Below we examine the current landscape for a vaccine against coronavirus development. This article is frequently updated and is intended to be a general overview, not a source of medical advice. If you are looking for more information on coronavirus testing, here you can find a test site near you, how to know if you are eligible for a test and how to get a home coronavirus test.






Now playing:
Check this out:

Prepare for a “new national monitoring system” to …




6:30

Important COVID-19 vaccine news

  • The first case of someone who contracted COVID-19 twice has been documented in USA by researchers at the University of Nevada, Reno School of Medicine, who say their discovery may not bode well for vaccines that are currently being developed.
  • Two vaccine frontrunners can be prohibitively difficult to make distributebecause the drugs, developed by Modern and Pfizer, require temperatures below zero during storage.
  • Vaccines may not be available immediately after FDA approval, according to Centers for Disease Control and Prevention Director Robert Redfield, who said we should expect a limited initial supply during a conference call Aug. 28.
  • The The CDC has released guidelines for the distribution of a coronavirus vaccine when one becomes available who would prioritize health care workers, necessary workers and vulnerable populations, such as the elderly.
  • About half of all voluntary open vaccine testing sites have been filled As of August, however, according to a Washington Post analysis, minorities appear to be underrepresented among volunteers.
  • You can volunteer for one of several clinical trials is testing a coronavirus vaccine, currently recruiting in the United States at CoronaVirusPreventionNetwork.org.
  • The US government has now pledged over $ 10 billion to several vaccine manufacturers to secure a total of 800 million doses as part of its Operation Warp Speed ​​vaccine acceleration program.
  • The UK has reserved 340 million doses under a similar program, while the EU has dealt with works that can amount to more than 1 billion doses.
coronavirus-face mask-face mask-health-7329

An effective coronavirus vaccine may be the only way to stop preventative measures, such as social distancing and face masks.

James Martin / CNET

The COVID vaccine is developing faster

Several acceleration efforts are currently underway, such as the White House’s Operation Warp Speed, which is intended to cut through the law firm to accelerate vaccine development and has hundreds of millions of vaccine doses ready to distribute as soon as they receive FDA approval.

Vaccines usually take about 10 to 15 years to develop and approve through four phases that include human trials. But with Operation Warp Speed, rather than submitting all parts of the application after all four phases have been completed, approved vaccine projects can send data to the FDA piece by piece.

At the same time, the program also supports financial support for starting production of doses while clinical trials are still ongoing. This means that if and when these vaccines are approved, there will already be a stock of doses ready to be distributed nationally. “I hope that by the time we get well into the second half of 2021, companies will have delivered the hundreds of millions of doses they have promised,” says Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told Forbes in August.

coronavirus-testing-hayward-ca-medical-doktorer-hospital-5833

Experts say that the recent increases in coronavirus cases are not only the result of the United States conducting more tests, as a higher proportion of those tested are positive compared to previous stages of the pandemic.

James Martin / CNET

Promising vaccines against coronavirus from the UK, USA, China

Here’s a quick look at some of the frontrunners in the race to find a vaccine against COVID-19, including where the vaccines are being developed, where they are being tested, and when researchers believe they may be ready for widespread distribution, if known.

Oxford University / AstraZeneca (UK): Currently testing its vaccine on 100,000 human volunteers in at least three countries. Leading researcher Dr. Sarah Gilbert has said that they are aiming for a release in the autumn of 2020.

Modern (US): An apparent mix of state regulators delayed large-scale human testing, but Modernes’ CEO has told Barrons that he still expects the company to know by Thanksgiving if the vaccine is safe and effective and should be able to distribute it in early 2021 if it does.

Pfizer (USA): Although its four COVID-19 vaccine candidates are still in early-stage human studies, two of them have been rapidly detected by the FDA. Pfizer’s business director told the US Congress that the company may be ready to apply for FDA approval in October.






Now playing:
Check this out:

Vaccines, antibody tests, treatments: The science of …




6:02

SinoVac (China): Currently testing its vaccine against about 10,000 human volunteers in China and about 9,000 in Brazil and will begin testing on about 1,900 test subjects in Indonesia soon. The CEO of BioPharma, SinoVac’s Indonesian partner, has said he expects the vaccine to be ready in early 2021.

SinoPharm (China): Currently testing about 15,000 volunteers in the Middle East in a trial that the state-owned company expects to last for three to six months. SinoPharm recently built a second plant to manufacture the vaccine and doubled its capacity to approximately 200 million doses per year.

CanSino Biologics (China): To begin major human trials this summer, CanSino’s vaccine has already been approved by the Chinese military.

header-04.png

Wearing a face mask is the safest way to prevent coronavirus transmission.

Robert Rodriguez / CNET

Will there just be one vaccine for everyone?

We probably won’t know until next year, but Fauci has suggested that it may take several different vaccines manufactured and distributed by different laboratories to end the pandemic, in an article published May 11 in the journal Science.

What happens if we never find a coronavirus vaccine?

Coronavirus is a large class of viruses and so far there are no vaccines against any of them. Although there are promising early results, there is no guarantee of a vaccine until 2021. Statistically, only about 6% of vaccine candidates have ever reached the market, according to a Reuters special report.

Early evidence suggests that the coronavirus does not appear to mutate as rapidly or frequently as the flu, and it is believed that the virus has not yet mutated sufficiently to interfere with vaccine development – although our knowledge may change.

coronavirus

Most experts expect a vaccine against the new coronavirus, SARS-CoV-2, by 2021.

James Martin / CNET

The further we go without a vaccine, the more likely the focus will shift to treatments, such as experimental antiviral drug remdesivir, which reportedly showed promising results, and dexamethasone, a steroid that doctors say increases the survival rate among the most serious cases. With effective therapeutic treatments, many viruses that used to be lethal are no longer death sentences. Patients with HIV, for example, can now expect to have the same life expectancy as non-HIV-positive individuals thanks to tremendous advances in treatment.

Eventually, the global population can reach the 60% to 70% required for flock immunity to protect those who are not immune, which is ultimately the goal of a vaccine.


Source link